WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Shared 1 month ago
50 views
Shared 1 month ago
28 views
Shared 1 month ago
46 views
Shared 1 month ago
22 views
Shared 2 months ago
40 views
Shared 2 months ago
73 views
Shared 6 months ago
31 views
Shared 6 months ago
23 views
Shared 6 months ago
30 views
Shared 6 months ago
15 views
Shared 9 months ago
143 views
Shared 1 year ago
158 views
Shared 1 year ago
245 views
Shared 1 year ago
203 views
Shared 1 year ago
80 views
Shared 1 year ago
41 views
Shared 1 year ago
238 views
Shared 1 year ago
61 views
Shared 1 year ago
184 views
Shared 1 year ago
385 views
Shared 1 year ago
124 views
Shared 1 year ago
50 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 1 year ago
65 views
Shared 1 year ago
62 views
Shared 3 years ago
34 views
Shared 3 years ago
112 views
Shared 3 years ago
49 views
Shared 3 years ago
57 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
193 views
Shared 3 years ago
10 views
Shared 3 years ago
60 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
48 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
13 views
Shared 3 years ago
8 views
Shared 3 years ago
35 views